Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | AR | P10275 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16387359 | 1.00 | SRD5A2 (0.40) | SRD5A2ESR1ARESR2 | |
| SCHEMBL16387362 | 0.90 | SRD5A2 (0.38) | SRD5A2ESR1ARESR2 | |
| SCHEMBL16387363 | 0.89 | SRD5A2 (0.38) | SRD5A2ESR1ARESR2 | |
| SCHEMBL16387346 | 0.86 | ESR1 (0.41) | SRD5A2ESR1ARESR2 | |
| SCHEMBL16387361 | 0.86 | ESR1 (0.41) | SRD5A2ESR1ARESR2 | |
| SCHEMBL15079280 | 0.86 | SRD5A2 (0.36) | SRD5A2 | |
| SCHEMBL17591546 | 0.76 | SRD5A2 (0.35) | SRD5A2 | |
| SCHEMBL16336390 | 0.76 | SRD5A2 (0.35) | SRD5A2 | |
| SCHEMBL16387350 | 0.74 | PGR (0.41) | SRD5A2ESR1ARESR2 | |
| SCHEMBL17634364 | 0.74 | PGR (0.41) | SRD5A2ESR1ARESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9296780-B2 | Process for alkynylating 16-substituted-17-keto steroids | CRYSTAL PHARMA, S.A.U. (ES) | 2016-03-29 | — | — | US | disclosed |
| US-20150005518-A1 | PROCESS FOR ALKYNYLATING 16-SUBSTITUTED-17-KETO STEROIDS | CRYSTAL PHARMA, S.A.U. (ES) | 2015-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150005518-A1 | PROCESS FOR ALKYNYLATING 16-SUBSTITUTED-17-KETO STEROIDS | HSD17B7, NR3C2, CYP17A1 | SRD5A2 75/4885ESR1 258/4885AR 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.